{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:58:58Z","timestamp":1774364338904,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Nusinersen is a disease-modifying drug for spinal muscular atrophy (SMA) that improves motor function. However, its effects on the skeletal muscles remain unclear. This study aimed to assess the intramuscular fat fraction in patients with SMA types II and III using muscle magnetic resonance imaging (MRI) and to explore the relationship between muscle tissue, lipid metabolism, and motor function during nusinersen treatment. Methods: This study included seven pediatric patients with SMA types II and III who received nusinersen treatment. Muscle MRIs were performed at three time points. Images of the central thigh were used to measure the cross-sectional area (CSA) and muscle fat area, and the intramuscular fat fraction (IMFF) was calculated. The thigh muscles were categorized into three groups: quadriceps, adductor, and hamstrings. Results: The median (range) of total IMFF for SMA type II and III at T-0, T-2, and T-4 were 18.5 (12.6\u201348.4), 24.4 (10.1\u201361.4), and 39.0 (30.0\u201368.6) % and increased over time. In five patients whose motor function was evaluated, a moderate negative correlation was observed between the changes in the Hammersmith Functional Motor Score Expanded (HSFME) and IMFF (r = \u22120.51). No significant changes in serum triglyceride or total cholesterol levels were observed during treatment. Conclusions: An increase in IMFF was associated with a decline in motor function. The baseline IMFF score was related to improvements in motor function scores, suggesting that the IMFF of the thigh muscle may serve as a novel, objective, and quantitative skeletal muscle-related biomarker for predicting the effects of nusinersen on muscle tissue.<\/jats:p>","DOI":"10.3390\/diagnostics15060753","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:04:22Z","timestamp":1742209462000},"page":"753","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III"],"prefix":"10.3390","volume":"15","author":[{"given":"Kiiko","family":"Iketani","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-4142","authenticated-orcid":false,"given":"Hiroyuki","family":"Awano","sequence":"additional","affiliation":[{"name":"Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Hashimura","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Sonehara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-7724","authenticated-orcid":false,"given":"Hiroaki","family":"Hanafusa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Nambu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6778-4511","authenticated-orcid":false,"given":"Hisahide","family":"Nishio","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0290-3137","authenticated-orcid":false,"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Bo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Nishio, H., Niba, E.T.E., Saito, T., Okamoto, K., Takeshima, Y., and Awano, H. (2023). Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241511939"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: Diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining Gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Crawford, T.O., Paushkin, S.V., Kobayashi, D.T., Forrest, S.J., Joyce, C.L., Finkel, R.S., Kaufmann, P., Swoboda, K.J., Tiziano, D., and Lomastro, R. (2012). Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033572"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","article-title":"Imaging of sarcopenia: Old evidence and new insights","volume":"30","author":"Albano","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New Effect Size Rules of Thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J. Mod. Appl. Stat. Methods"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, and National Heart, Lung, and Blood Institute (2011). Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics, 128, S213\u2013S256.","DOI":"10.1542\/peds.2009-2107C"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02015357","article-title":"Spinal muscular atrophy: MR Evaluation","volume":"22","author":"Liu","year":"1992","journal-title":"Pediatr. Radiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.25385","article-title":"Muscle magnetic resonance imaging in spinal muscular atrophy type 3: Selective and progressive involvement","volume":"55","author":"Durmus","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00415-019-09646-w","article-title":"MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients","volume":"267","author":"Brogna","year":"2020","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0883073810380457","article-title":"Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy","volume":"26","author":"Sproule","year":"2011","journal-title":"J. Child Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chabanon, A., Seferian, A.M., Daron, A., Pereon, Y., Cances, C., Vuillerot, C., De Waele, L., Cuisset, J.M., Laugel, V., and Schara, U. (2018). Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201004"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Otto, L.A.M., Froeling, M., van Eijk, R.P.A., Asselman, F.L., Wadman, R., Cuppen, I., Hendrikse, J., and van der Pol, W.L. (2021). Quantification of Disease Progression in Spinal Muscular Atrophy with Muscle Mri\u2014A Pilot Study. NMR Biomed., 34.","DOI":"10.1002\/nbm.4473"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e209151","DOI":"10.1212\/WNL.0000000000209151","article-title":"Safety and Efficacy of Apitegromab in Patients with Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study","volume":"102","author":"Crawford","year":"2024","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JND-221671","article-title":"Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI","volume":"11","author":"Otto","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.braindev.2022.11.002","article-title":"Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study","volume":"45","author":"Chiba","year":"2023","journal-title":"Brain Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/ene.15768","article-title":"Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function","volume":"30","author":"Pane","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_22","first-page":"55","article-title":"Newbornscreening SMA\u2014From Pilot Project to Nationwide Screening in Germany","volume":"10","author":"Blaschek","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sonehara, S., Bo, R., Nambu, Y., Iketani, K., Lee, T., Shimomura, H., Ueda, M., Takeshima, Y., Iijima, K., and Nozu, K. (2023). Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan. Genes, 14.","DOI":"10.3390\/genes14122211"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zaidman, C.M., Crockett, C.D., Wedge, E., Tabatabai, G., and Goedeker, N. (2024). Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10030058"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/acn3.50855","article-title":"Abnormal fatty acid metabolism is a core component of spinal muscular atrophy","volume":"6","author":"Deguise","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Miletic, M., Stevic, Z., Vujovic, S., Rakocevic, J., Tomic, A., Gajic, M.T., Stojanovic, M., Palibrk, A., and Zarkovic, M. (2024). Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3. Diagnostics, 14.","DOI":"10.3390\/diagnostics14182078"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jcmgh.2021.01.019","article-title":"SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease","volume":"12","author":"Deguise","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12603-010-0081-2","article-title":"Skeletal muscle fat infiltration: Impact of age, inactivity, and exercise","volume":"14","author":"Marcus","year":"2010","journal-title":"J. Nutr. Health Aging"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yoshiko, A., Hioki, M., Kanehira, N., Shimaoka, K., Koike, T., Sakakibara, H., Oshida, Y., and Akima, H. (2017). Three-Dimensional Comparison of Intramuscular Fat Content between Young and Old Adults. BMC Med. Imaging, 17.","DOI":"10.1186\/s12880-017-0185-9"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ajcn\/85.2.377","article-title":"Reduced Physical Activity Increases Intermuscular Adipose Tissue in Healthy Young Adults","volume":"85","author":"Manini","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109221","DOI":"10.1016\/j.isci.2024.109221","article-title":"Fat Infiltration in Skeletal muscle: Influential triggers and regulatory mechanism","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1093\/hmg\/ddu189","article-title":"Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics","volume":"23","author":"Bricceno","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hellbach, N., Peterson, S., Haehnke, D., Shankar, A., LaBarge, S., Pivaroff, C., Saenger, S., Thomas, C., McCarthy, K., and Ebeling, M. (2018). Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205589"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/753\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:08Z","timestamp":1760028908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diagnostics15060753"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15060753","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]}}}